Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind, randomized cross-over pilot phase II trial

Authors :: Hélio Pinczowski
Fernando Luiz Affonso Fonseca
F. Schindler
A. Del Giglio
Rebecca Melo Zanellato
Geila Ribeiro Nuñez
L. C. Tateyama
Source :: Journal of Clinical Oncology. 29:9102-9102
Publication Year :: 2011
Publisher :: American Society of Clinical Oncology (ASCO), 2011.
Abstract: 9102 Background: Hot flashes and sexual dysfunction often affect breast cancer's survivors compromising their quality of life. Approximately 65% of women after treatment for breast cancer complain ...

Subjects :: Pilot phase
Bupropion
Cross over
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
Affect (psychology)
Double blind
Breast cancer
Sexual dysfunction
Oncology
Quality of life
Internal medicine
medicine
medicine.symptom
skin and connective tissue diseases
business
medicine.drug

Full Text Access

Tools